Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

Ozempic face is not a direct side effect of the drug itself but rather a consequence of fat loss, which can cause skin laxity ...

Topline data were announced from a phase 3b trial evaluating investigational semaglutide 7.2mg in adults with obesity.

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

Ozempic and other semaglutide medications have skyrocketed in popularity as weight-loss aids, with prescriptions surging by ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

MoD says semaglutide prescriptions are likely for diabetes, as more than 81 troops have received the medication ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

The research found that participants who used the class of drugs which includes Wegovy and Ozempic had a lower risk of 42 ...

Novo Nordisk A/S, GE HealthCare Technologies Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com ...

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity ...